Literature DB >> 30977559

Formative research for the development of an Eye Health Strategic Planning and Evaluation Framework and a Checklist: A health systems approach.

Gail M Ormsby1,2.   

Abstract

This formative research process aimed to develop an Eye Health Strategic Planning and Evaluation Framework and indicator Checklist. The research process utilized a multi-phased multiple methods approach including literature review, initial expert review (n = 27), findings from a Cambodian Avoidable Blindness Initiative demonstration project (2009-2012), observation and analysis of four rural sites of the Indian LV Prasad Eye Institute Pyramid Model (n = 21), and finally, a critique by Cambodian government eye health professionals/staff (n = 15), health center staff and community representatives (n = 77) and patients (n = 62). Results from three Cambodian population-based surveys (KAP n = 599, patient follow-up n = 354, and RAAB 4650) also informed the development of the Framework and the Checklist. The Framework domains include: situation analysis, determinants of accessibility, service delivery systems, operation systems, networks and linkages, outcomes, and impact. Domains were subdivided into 59 components. The Checklist consists of 253 indicator items. The Eye Health Strategic Planning and Evaluation Framework and the Checklist can assist policy makers, program planners, and evaluators to develop a comprehensive whole of systems approach to eye health care to improve coverage and utilization of services.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  comprehensive; eye health care; health systems; health systems research; integrated

Year:  2019        PMID: 30977559     DOI: 10.1002/hpm.2784

Source DB:  PubMed          Journal:  Int J Health Plann Manage        ISSN: 0749-6753


  1 in total

Review 1.  Exploring eye care pathways, patient priorities and economics in Pakistan: A scoping review and expert consultation study with thematic analysis.

Authors:  Manal Malik; Niall Strang; Pauline Campbell; Sven Jonuscheit
Journal:  Ophthalmic Physiol Opt       Date:  2022-03-23       Impact factor: 3.992

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.